Anne Montgomery

BioProcess International magazine editor in chief -- always looking for hot topics and people eager to write about them!

[BioTechniques @MyBioTechniques]

An unexpected discovery turns into a useful tool for #CRISPR technology .@AprilPawluk .@UofT .@lnhandly https://t.co/rSa51GO6gt

[Anne Montgomery @BPI_Anne]

@WolfgangWeinkum @Bioprocess365 Looking forward to it!

[Anne Montgomery @BPI_Anne]

Add your voice to BPI's 15th-anniversary State of the Industry issue (June) - take our survey! (good prizes, too) https://t.co/O6qe8OiaxO

[Lonza Drug Product @LonzaDPS]

#LonzaDrugProduct expert M. Jahn featured in @BioProcessIntl ebook on Extractables & Leachables. Read ebook here: https://t.co/L7MsYd8ofB

[Amgen 🧪🔬🧬 @Amgen]

This month, we’re busting the craziest #cholesterol and #heartdisease myths to help show healthy lifestyle tips! #AmgenCV

[Anne Montgomery @BPI_Anne]

How are new technologies driving innovations in health sciences? Download the report at https://t.co/Dy7C2u6W5H #SCORR #KNect365

[Anne Montgomery @BPI_Anne]

Be part of the conversations at “Cell and Gene Therapy Exchange” for regulatory, business, and patient advocates https://t.co/VIY87DmbH5

[Anne Montgomery @BPI_Anne]

Nice graphic and short commentary on the progress and evolution of US biosimilars #GaBi https://t.co/fCCfIBrun8

[Anne Montgomery @BPI_Anne]

Kudos to Patheon for leading in new drug approvals! https://t.co/kVgYDKUtCC

[Anne Montgomery @BPI_Anne]

Kite Pharma and IsoPlexis collaborate toward a single-cell platform to predict patient response to T-Cell Therapy. https://t.co/G4jb6n5FoO

[Anne Montgomery @BPI_Anne]

A good summary of recent approval recommendations from the EMA -- good to see orphan drugs in the mix. https://t.co/1Pz6niQdWc

[Anne Montgomery @BPI_Anne]

BPI's Sr. Technical Editor, Cheryl Scott, explains the added Product Development theme in our 15th anniversary year, https://t.co/CeSeT6J8xZ

[Anne Montgomery @BPI_Anne]

Best practices (and more) for combination-product development in BPI’s March issue, https://t.co/7zzTfkWpX2 #CASSS #bioprocess

[Anne Montgomery @BPI_Anne]

So how big IS “big data?” And why should you care? Read about it in BPI’s March issue! https://t.co/w5fYiBY6q0

[Anne Montgomery @BPI_Anne]

BPI March issue featured report now available: Outsourcing: Who, What, When, Where, and How? https://t.co/RzyMeTrh3I

[Anne Montgomery @BPI_Anne]

Also on the topic: Watch for BPI's March article on advanced gene-editing techologies -- available online soon! #bioprocess https://t.co/4HlbZYI72g

[Bio-Rad Life Science @BioRadLifeSci]

Developing new #therapeutics? Learn how #CRISPR, is shaking up Drug Discovery and Development? https://t.co/O8FEhceR0v #genes

[Anne Montgomery @BPI_Anne]

Another good course offering: “Commissioning and Qualification for New and Renovated Facilities” #NIBRT #bioprocess https://t.co/8fF59uLhDg

[EBD Group @EBDgroup]

Access a world of opportunities at our premier springtime partnering conference #BIOEuropeSpring REGISTER NOW >> https://t.co/j1VDis60gK

[Anne Montgomery @BPI_Anne]

Pros and cons of additional 6 months of exclusivity for manufacturers of biosimilars? Implications? https://t.co/EExYcGDo3a